The press releases contained in this section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Medicis has no obligation to update any information contained in such press releases after the date of their issuance. For current information about the Company, please refer to our most recent public filings with the Securities and Exchange Commission.

Note that in November 2008 the Company restated its financial statements for the annual, transition and quarterly periods in fiscal years 2003 through 2007 and the first and second quarters of 2008, and, accordingly, filed an amended annual report on Form 10-K/A for the year ended December 31, 2007, and amended quarterly reports on Forms 10-Q/A for the quarters ended March 31, 2008, and June 30, 2008. Readers are cautioned to refer to the SEC filings associated with the Company's restatement for correct financial data.

Receive all Medicis press releases via email

View the Medicis Press Release Archive

2003 Press Releases
Keyword Search:  
Dec 22, 2003
Medicis Discontinues PVAC Development
Dec 16, 2003
Medicis Declares Cash Dividend
Dec 12, 2003
Medicis Announces FDA Approval of Restylane, the First and Only Dermal Filler Made of Stable, Biodegradable Non-Animal Hyaluronic Acid
Nov 21, 2003
Medicis Announces RESTYLANE's Recommendation from FDA Advisory Panel
Nov 21, 2003
Medicis Stock Trading to Halt as FDA Advisory Panel Reviews RESTYLANE
Nov 20, 2003
Medicis Announces FDA Advisory Panel Information Available on FDA Website
Nov 19, 2003
Medicis Announces Conference Call to Review FDA Advisory Panel Proceedings
Oct 30, 2003
Medicis Reports First Quarter Fiscal 2004 Financial Results
Oct 27, 2003
Medicis Announces First Quarter Fiscal 2004 Conference Call and Webcast
Sep 19, 2003
Medicis Declares Cash Dividend
Sep 10, 2003
Medicis Announces FDA Advisory Panel for RESTYLANE
Aug 28, 2003
Medicis to Present at Thomas Weisel Partners Healthcare Tailwinds 2003 Conference
Aug 26, 2003
Medicis Reports Fourth Quarter and Year-End Fiscal 2003 Financial Results
Aug 21, 2003
Medicis Announces Fiscal 2003 Fourth Quarter and Year-End Conference Call and Webcast
Aug 18, 2003
Medicis Announces Successful Completion of Exchange Offer
Aug 13, 2003
Medicis Announces Initial Results of Exchange Offer
Jul 16, 2003
Medicis Files Exchange Offer for Convertible Notes
Jun 26, 2003
Medicis Announces Fiscal 2004 Guidance
Jun 23, 2003
Medicis Announces Fiscal 2004 Guidance Conference Call and Webcast
Jun 12, 2003
Medicis Declares Cash Dividend
Jun 12, 2003
Medicis to Present at Thomas Weisel Partners Growth Forum 5.0
May 30, 2003
Medicis to Present at UBS Warburg Global Specialty Pharmaceuticals Conference
May 1, 2003
Medicis to Present at Deutsche Bank 2003 Health Care Conference
Apr 22, 2003
Medicis Reports Third Quarter Fiscal 2003 Financial Results
Apr 17, 2003
Medicis Announces Fiscal 2003 Third Quarter Conference Call and Webcast
Apr 16, 2003
Medicis Announces FDA Approval of DYNACIN -minocycline HCl- Tablets
Mar 24, 2003
Medicis to Present at Banc of America Securities 2003 Healthcare Conference
Mar 10, 2003
Medicis Closes Acquisition of Dermal Filler Product Lines
Mar 4, 2003
Medicis Receives Hart-Scott-Rodino Clearance on Acquisition of Dermal Filler Product Lines
Mar 3, 2003
Medicis Announces FDA Approval of LOPROX Shampoo -ciclopirox- 1%
Feb 27, 2003
Medicis to Present at Salomon Smith Barney Third Annual Specialty Pharmaceuticals Conference
Feb 10, 2003
Medicis Announces Conference Call and Webcast to Review Exclusive License for Dermal Filler Product Lines
Feb 10, 2003
Medicis Agrees to Acquire Company with Exclusive License for Dermal Filler Product Lines
Jan 22, 2003
Medicis Reports Second Quarter Fiscal 2003 Financial Results
Jan 17, 2003
Medicis Announces Fiscal 2003 Second Quarter Conference Call and Webcast
Jan 15, 2003
Taro to License Four Branded Pharmaceutical Product Lines from Medicis
© 1996-2010 Medicis Pharmaceutical Corp